contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


bicos-kalender-for-finansiell-rapportering-h2-2024-och-2025

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

BICO Group is active in medical technology. The company specializes in bio convergence and provides technology, products, and services for biology. With a focus on the application areas bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets technology that enables researchers to grow cells in 3D environments, conduct drug screening, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.

BICO Group

BICO Group AB 559050–5052 (NASDAQ STOCKHOLM: BICO)BICOs kalender för finansiell rapportering: H2 2024 och 2025Q3-rapport 2024: 26 november, 2024, 07:00 CETBokslutskommuniké 2024: 19 februari...

<div class="mfn-preamble"><p><strong>BICO Group AB 559050–5052 (NASDAQ STOCKHOLM: BICO)</strong></p></div><div class="mfn-body"><p><strong>BICOs kalender för finansiell rapportering: H2 2024 och 2025</strong></p><ul><li>Q3-rapport 2024: 26 november, 2024, 07:00 CET</li><li>Bokslutskommuniké 2024: 19 februari, 2025, 07:00 CET</li><li>Årsredovisning 2024: 20 mars, 2025, offentliggörande under dagen</li><li>Q1-rapport 2025: 29 april, 2025, 07:00 CEST</li><li>Årsstämma 2025: 8 maj, 2025. Tid kommer meddelas i kallelse till Årsstämma 2025</li><li>Q2-rapport 2025: 19 augusti, 2025, 07:00 CEST</li><li>Q3-rapport 2025: 4 november, 2025, 07:00 CET</li><li>Bokslutskommuniké 2025: 10 februari, 2026, 07:00 CET</li></ul><p>Vänligen notera att, som kommunicerades under kapitalmarknadsdagen och på grund av den nya affärsområdesstrukturen så kommer, BICOs Q3-rapport 2024 offentliggörs tisdagen den 26 november 2024, klockan 07:00 CET.</p></div><div class="mfn-footer mfn-3bedbe434cfb"><p><strong class="mfn-heading-1">För mer information, vänligen kontakta:</strong><br>Jacob Thordenberg, CFO, BICO Group AB<br>Telefon: +46 735 34 88 84<br>E-post:&nbsp;<a rel="noopener" href="mailto:jt@bico.com">jt@bico.com</a></p></div><div class="mfn-footer mfn-016007b7c962"><p><em>Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 18 oktober 2024 kl. 07:00 CEST.</em></p></div><div class="mfn-footer mfn-31d379c491ca"><p><a rel="noopener" href="https://bico.com/se/">BICO</a> är en partner inom labautomation och tillhandahåller utvalda arbetsflöden till pharma och bioteknik. Med 46 000+ instrument installerade i över 65 länder, finns BICOs produkter, mjukvara och lösningar i fler än 3 500 laboratorier, inklusive världens 20 främsta läkemedelsföretag, och har citerats i över 12 000 publikationer. Genom tre affärsområden – Lab Automation, Life Science Solutions och Bioprinting – strävar BICO mot visionen att möjliggöra och automatisera framtidens life science-lab. BICO är noterat på Mid-Cap, Nasdaq Stockholm under BICO. <a rel="noopener" href="http://www.bico.com">www.bico.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Bifogade filer</strong><br><a rel="noopener" href="https://storage.mfn.se/572a0307-208b-4554-ba82-3b79fc3e0f77/bicos-kalender-for-finansiell-rapportering-h2-2024-och-2025.pdf" class="mfn-generated mfn-primary">BICOs kalender för finansiell rapportering: H2 2024 och 2025</a></p></div>

BICOs kalender för finansiell rapportering: H2 2024 och 2025

Return on capital (ROE, ROI, ROIC, RONIC)

What does negative working capital mean and why is it a good thing?

Drug development investment: Value creation through M&As and licensing agreements

Income statement

Amazon continues to grow in Sweden

Stay up to date with our newsletter